![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
01 SANOFI SRL (3)
02 SANOFI SpA (3)
03 Sanofi-Aventis (Suisse) SA (12)
04 Sanofi-aventis Norway (3) (5)
05 ACCORD HEALTHCARE LIMITED (3)
06 ACCORD HEALTHCARE SLU (3)
07 ACCORD HLTHCARE (3)
08 ACTAVIS GROUP PTC EHF (3)
09 ANGENERICO SpA (1)
10 AUROBINDO PHARMA ITALIA SRL (3)
11 Actavis Switzerland AG (8)
12 CHARTWELL MOLECULAR (3)
13 EG SPA (1)
14 EG SpA (1)
15 GUIDOTTI SPA LABORATORIES (3)
16 Hexal A/S (5)
17 INDOCO REMEDIES (3)
18 LABORATORI GUIDOTTI SpA (3)
19 MYLAN SpA (1)
20 Mepha Pharma AG (10)
21 PRINSTON INC (4)
22 S.F.GROUP Srl (1)
23 SANDAZ GMBH (3)
24 SANDOZ GMBH (3)
25 SANDOZ SpA (1)
26 Sandoz Pharmaceuticals AG (8)
27 TAKEDA PHARMA A/S (2)
28 Teva Sweden AB (5)
29 Blank (62)
01 GLIMEPIRIDE (13)
02 Glimepiride (151)
03 Pioglitazone; Glimepiride (2)
01 Italy (38)
02 Norway (15)
03 Spain (62)
04 Switzerland (38)
05 USA (13)
01 Antic-calc Tablet (15)
02 Glimepiride 2Mg 30 Joined' Oral Use (10)
03 Glimepiride 3Mg 30 Joined' Oral Use (5)
04 Glimepiride 4Mg 30 Joined' Oral Use (5)
05 Pioglitazone+Glimepiride 30+2Mg 28 Combined Oral Use (1)
06 Pioglitazone+Glimepiride 30+4Mg 28 Combined Oral Use (1)
07 TABLET;ORAL (13)
08 Tablet (100)
09 Tablets (16)